2024 Nucleic Acid Drugs and mRNA Vaccine Industry Summit March 28-29, Shanghai

01 Conference theme setting

theme I:Innovative research and development of nucleic acid drugs and breakthroughs in new technologies

theme II:Process development and quality control

theme III: New efficient nucleic acid delivery technology

topic IV:New mRNA vaccines and drug development

限/量/免/fee/参/会/门/票**/领/取**

(Please note when adding WeChat:Your unit and name, attend nucleic acid conference)

** **

Special guest lineup at the 02 Conference

03 Detailed schedule of the conference

- March 28, Small Nucleic Acid Drug Conference A-

Novel lipid nanoparticle mRNA delivery system

Li Jianguang, Chief Scientist and Professor of Haichang Biology

theme to be determined

He Qizhi, CEO of Kemeilian Biotech

Evolution and challenges of RNA-targeted therapy

Jiang Weiwen, Shi Nengkang Pharmaceutical, co-founder, head of preclinical R & D

round-table discussions :Challenges in source innovation and industrial transformation of nucleic acid drugs?

TBD

Development and application of circular RNA in vaccines and cell therapies

Zuo Chijian, Chief Scientist and Co-Founder of Kerimaide Biotech

Development and future prospects of small nucleic acid drugs

Li Qing, Junmeng Biotech, Director of Small Nucleic Acid Drug Research and Development

Technical characteristics and research and development progress of siRNA drugs for hypertension treatment

Liu Nan, co-founder of Shi 'an Biotech

ASO for targeted RNA therapy

Xin Rong, CEO of Shi Xi (Guangzhou) Biotech

Suppressor tRNA for treatment of nonsense mutation genetic diseases

Kong Lingjie, co-founder of Science and Technology Biotech

theme to be determined

Fu Zheng, Professor, Nanjing University

Delivery of small nucleic acid drugs and CMC strategy

Huang Zeao, Director of Small Nucleic Acid Development, Yuekang Pharmaceutical

- March 28 mRNA Vaccine Conference B-

Development of COVID-19 variant mRNA vaccine
Qiu Yuanzheng, General Manager of the Vaccine Clinical Center of Shijiazhuang Pharmaceutical Group

** Research and development of an industrialized and engineered cell-targeted delivery platform for new ionizable amino lipids
Zha Gaofeng, CEO of Shenzhen Hongxin Biotech **

** Evaluation of humanized mice and their tumor vaccines
Huang Jing, Future Model, Chairman **

** Theme to be determined
Li Shiyou, Qi Chensheng, Co-Founder, CTO**

** Roundtable discussion :New therapeutic changes brought about by mRNA technology, next-generation mRNA technology and research and development trends?
**

TBD

Research progress in mRNA underlying technology
Wang Haomeng, Deputy General Manager of Concino Shanghai Pharmaceutical evaluation of self-replicating mRNA drugs
Wang Zhaoyang, Junjian Bio, Immunologist Subject to be determined
Wang Peng, Chairman, Materials Science Innovation in Medicine:mRNA-based Therapeutics
Kong Na, researcher at Zhejiang University Research Progress on BH-RACETM New Nucleic Acid Drug Platform
Hu Han, Binhui Biotech, Vice President, Risk-Based Conversion of mRNA Products
Zhao Hui, Senior Quality Director, Fosun Pharma Shanghai Kaimao Biomedical Co., Ltd.

- March 29, Small Nucleic Acid Drug Conference A-

lncRNA opens up a new direction for nucleic acid drugs

Song Xu, founder of Chengdu Lingtai Krypton Biotech, professor at Sichuan University

** **

Key challenges and research and development progress in nucleic acid pharmaceuticals

Huang Yuanyu, founder of Suzhou Xuanjing Biosciences, professor at Beijing Institute of Technology

** **

Research on nucleic acid drugs targeting nucleic acids and proteins

Tang Xinjing, Professor, School of Pharmacy, Peking University

** **

Application of antisense oligonucleotides without delivery system in the treatment of chronic diseases and tumors

Chen Shengpei, CEO of Hard Nucleic Acid Biotechnology Co., Ltd.

** **

Organ specific mRNA transfection and drug delivery system

Shen Youqing, Dean of the School of Chemical Engineering and Bioengineering, Zhejiang University

** **

Introduction to Innovative Technology for siRNA Delivery

Yu Jianxiu, Distinguished Professor and Deputy Director of the Department of Biochemistry, School of Medicine, Shanghai Jiao Tong University

** **

Development and application of biodegradable siRNA delivery vector

Yang Chengbin, Assistant Professor and Associate Researcher, Shenzhen University

** **

Technical strategies to improve siRNA silencing effectiveness

Huang Yi, President of the Research Institute of Chengdu Guowei Biology

** **

- March 29 mRNA Vaccine Conference B-

mRNA vaccine drug development and technological innovation
Zhang Weiguo, Renjing Biotech, Innovation Manager

** Application of targeted delivery in mRNA drug development
Yu Xueliang, Vice President of Xingrui Pharmaceutical **

** Exploration of targeted delivery strategies for thick storage nano nucleic acids
Zhang Longgui, Houcun Nano, founder **

** LNP delivery system R & D strategy and application
Chen Dan, Vice President, Xinghe Dicai Biotechnology Co., Ltd. **

** New therapies for regenerative medicine based on mRNA technology
Fu Wei, researcher, Shanghai Jiao Tong University

Efficient development of veterinary mRNA vaccines
Fei Caiyi, Vice President of Nanjing Chengshi Biotech **

** Replicating mRNA (alphavirus vector) and its application
Zhang Bo, Researcher, Center for Emerging Infectious Diseases, Wuhan Institute of Virus **

** Protein translation control and vaccine sequence optimization
Lu Jian, Professor, School of Life Sciences, Peking University **

限/量/免/fee/参/会/门/票**/领/取！！！**/

free tickets

** Step 1:Scan the QR code below to register for pre-registration